scPharmaceuticals Inc.
SCPHDelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001604950
scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding scPharmaceuticals Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 40 | 59 | +19 |
| Shares | 14.0M | 21.4M | +7.39M (+52.7%) |
| Value | $91.3M | $153.5M | +$62.2M (+68.2%) |
New holders (25)
Institutions that held scPharmaceuticals Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (6)
Institutions that held scPharmaceuticals Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Ikarian Capital, LLC | 479,383 | $3.13M |
| Belvedere Trading LLC | 120,706 | $661.0K |
| Wolverine Trading, LLC | 23,282 | $141.0K |
| Ritholtz Wealth Management | 15,000 | $98.0K |
| Envestnet Asset Management Inc | 14,186 | $92.0K |
| Royal Bank of Canada | 12 | $0 |